Iovance Biotherapeutics, Inc. (IOVA)

NASDAQ: IOVA · IEX Real-Time Price · USD

11.86

+0.54 (4.77%)

At close: Apr 23, 2024, 4:00 PM

12.13

+0.27 (2.28%)

After-hours: Apr 23, 2024, 7:59 PM EDT

Iovance Biotherapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2007
Revenue	1.19	0	0	0	0	0	0	0	0	0	Upgrade
Cost of Revenue	10.76	0	0	0	0	0	0	0	0	0	Upgrade
Gross Profit	-9.57	0	0	0	0	0	0	0	0	0	Upgrade
Selling, General & Admin	106.92	104.1	83.66	60.21	40.85	28.43	21.26	26.7	12.39	8.19	Upgrade
Research & Development	344.08	294.78	259.04	201.73	166.02	99.83	71.62	26.94	15.47	3.85	Upgrade
Operating Expenses	450.99	398.88	342.7	261.94	206.87	128.26	92.88	53.64	27.86	12.04	Upgrade
Operating Income	-460.56	-398.88	-342.7	-261.94	-206.87	-128.26	-92.88	-53.64	-27.86	-12.04	Upgrade
Other Expense / Income	-13.04	-2.99	-0.45	-2.36	-9.32	-4.68	-0.81	-0.75	-0.2	-0.01	Upgrade
Pretax Income	-447.52	-395.89	-342.25	-259.58	-197.56	-123.58	-92.06	-52.89	-27.66	-12.04	Upgrade
Income Tax	-3.48	0	0	0	0	0	0	0	0	0	Upgrade
Net Income	-444.04	-395.89	-342.25	-259.58	-197.56	-123.58	-92.06	-52.89	-27.66	-12.04	Upgrade
Preferred Dividends	0	0	0	0	0	0	0	49.45	0	0	Upgrade
Net Income Common	-444.04	-395.89	-342.25	-259.58	-197.56	-123.58	-92.06	-102.35	-27.66	-12.04	Upgrade
Shares Outstanding (Basic)	235	159	153	138	124	97	65	55	44	25	Upgrade
Shares Outstanding (Diluted)	235	159	153	138	124	97	65	55	44	25	Upgrade
Shares Change	47.64%	3.82%	10.92%	11.23%	27.82%	49.10%	18.05%	24.45%	77.74%	155.94%	Upgrade
EPS (Basic)	-1.89	-2.49	-2.23	-1.88	-1.59	-1.27	-1.41	-1.85	-0.62	-0.48	Upgrade
EPS (Diluted)	-1.89	-2.49	-2.23	-1.88	-1.59	-1.27	-1.41	-1.85	-0.62	-0.48	Upgrade
Free Cash Flow	-384.11	-313.18	-265.52	-251.93	-165.81	-102.45	-79.74	-34.19	-19.52	-10.23	Upgrade
Free Cash Flow Per Share	-1.63	-1.97	-1.73	-1.82	-1.33	-1.05	-1.22	-0.62	-0.44	-0.41	Upgrade
Gross Margin	-804.54%	-	-	-	-	-	-	-	-	-	Upgrade
Operating Margin	-38734.99%	-	-	-	-	-	-	-	-	-	Upgrade
Profit Margin	-37345.42%	-	-	-	-	-	-	-	-	-	Upgrade
Free Cash Flow Margin	-32305.30%	-	-	-	-	-	-	-	-	-	Upgrade
EBITDA	-414.39	-374.76	-328.27	-250.87	-189.43	-122.62	-91.11	-51.92	-26.66	-11.95	Upgrade
EBITDA Margin	-34851.89%	-	-	-	-	-	-	-	-	-	Upgrade
Depreciation & Amortization	33.13	21.14	13.98	8.71	8.12	0.96	0.95	0.98	1	0.09	Upgrade
EBIT	-447.52	-395.89	-342.25	-259.58	-197.56	-123.58	-92.06	-52.89	-27.66	-12.04	Upgrade
EBIT Margin	-37638.02%	-	-	-	-	-	-	-	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).